Magevac recombinant live vaccinia virus: Began Phase I/II trial

Therion Biologics Corp., Cambridge, Mass. Product: Magevac recombinant live vaccinia virus carrying the human gene for the tumor-specific peptide MAGE-1; the MAGE-1 gene is modified so that following ...